EQUINOX NEPREMICNINE d.d. Share Price
Equities
EQNX
SI0031117813
Real Estate Development & Operations
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
54 EUR | 0.00% | 0.00% | +2.86% |
2022 | An unknown buyer acquired an unknown minority stake in EQUINOX NEPREMICNINE d.d. from Axor holding d.d. | CI |
2022 | EQUINOX NEPREMICNINE d.d. has completed an IPO. | CI |
Sales 2022 | 7.34M 7.85M 629M | Sales 2023 | 7.79M 8.33M 667M | Capitalization | 94.18M 101M 8.07B |
---|---|---|---|---|---|
Net income 2022 | - 0 0 | Net income 2023 | - 0 0 | EV / Sales 2022 | 12.7 x |
Net Debt 2022 | 3.79M 4.05M 324M | Net Debt 2023 | 5.23M 5.59M 448M | EV / Sales 2023 | 12.8 x |
P/E ratio 2022 |
126
x | P/E ratio 2023 |
108
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 36.44% |
Current month | +2.86% | ||
1 month | +2.86% | ||
3 months | +3.85% | ||
6 months | +2.86% | ||
Current year | +2.86% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Krivc
CEO | Chief Executive Officer | - | 02/05/21 |
Matej Rigelnik
PRN | Corporate Officer/Principal | - | 02/05/21 |
Tadeja Celar
PRN | Corporate Officer/Principal | - | 02/05/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Krivc
CEO | Chief Executive Officer | - | 02/05/21 |
Tadeja Celar
PRN | Corporate Officer/Principal | - | 02/05/21 |
Matej Rigelnik
PRN | Corporate Officer/Principal | - | 02/05/21 |
Date | Price | Change | Volume |
---|---|---|---|
24/04/24 | 54 | 0.00% | 150 |
23/04/24 | 54 | 0.00% | 150 |
22/04/24 | 54 | 0.00% | 115 |
End-of-day quote Ljubljana S.E., April 23, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+2.86% | 103M | |
+36.16% | 27.94B | |
-13.74% | 26.97B | |
+25.00% | 26.95B | |
-0.71% | 25.32B | |
+44.49% | 22.58B | |
+2.78% | 19.59B | |
+1.45% | 19.52B | |
+28.54% | 16.23B | |
-14.80% | 14.98B |
- Stock Market
- Equities
- EQNX Stock